Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China.

MLA

Zhou, Na, et al. “Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China.” Oncologist, vol. 24, no. 6, June 2019, pp. 812–19. EBSCOhost, https://doi.org/10.1634/theoncologist.2018-0255.

APA

Zhou, N., Zhang, C., Lv, H., Hao, C., Li, T., Zhu, J., Zhu, H., Jiang, M., Liu, K., Hou, H., Liu, D., Li, A., Zhang, G., Tian, Z., & Zhang, X. (2019). Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China. Oncologist, 24(6), 812–819. https://doi.org/10.1634/theoncologist.2018-0255

Chicago

Zhou, Na, Chuan‐Tao Zhang, Hong‐Ying Lv, Chen‐Xing Hao, Tian‐Jun Li, Jing‐Juan Zhu, Hua Zhu, et al. 2019. “Concordance Study Between IBM Watson for Oncology and Clinical Practice for Patients with Cancer in China.” Oncologist 24 (6): 812–19. doi:10.1634/theoncologist.2018-0255.